Advertisement
Abstract| Volume 46, SUPPLEMENT 2, e43-e44, January 2018

Molecular mechanisms of neurodegeneration and neuroplasticity in the nigrostriatal system at modeling Parkinson’s disease as an instrument for translational medicine

      Objective: Parkinson’s disease (PD) is characterized by the appearance of motor symptoms many years after the onset of neurodegeneration, which explains low efficiency of therapy. The objective of our work was to study molecular mechanisms of neurodegeneration and neuroplasticity in the nigrostriatal system at modeling preclinical and clinical stages of PD that would serve to develop preclinical diagnosis and preventive therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect